Increased PD-L1 Expression May Be Associated With the Cytokine Storm and CD8+ T-Cell Exhaustion in Severe COVID-19.
作者信息
Chen Jiezhong, Vitetta Luis
机构信息
Research Department, Medlab Clinical, Sydney, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
出版信息
J Infect Dis. 2021 May 20;223(9):1659-1660. doi: 10.1093/infdis/jiab061.
Abstract
摘要
相似文献
1
Increased PD-L1 Expression May Be Associated With the Cytokine Storm and CD8+ T-Cell Exhaustion in Severe COVID-19.PD-L1表达增加可能与重症COVID-19中的细胞因子风暴和CD8 + T细胞耗竭有关。
J Infect Dis. 2021 May 20;223(9):1659-1660. doi: 10.1093/infdis/jiab061.
2
PD-L1 Overexpression in the Lungs of Subjects Who Died from COVID-19: Are We on the Way to Understanding the Immune System Exhaustion Induced by SARS-CoV-2?COVID-19 死亡患者肺部的 PD-L1 过表达：我们是否正在了解由 SARS-CoV-2 引起的免疫系统衰竭？
Crit Rev Eukaryot Gene Expr. 2022;32(3):9-20. doi: 10.1615/CritRevEukaryotGeneExpr.2021040575.
3
Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection.病例报告：COVID-19 感染后炎症性结肠炎的一个特殊病例。
Front Immunol. 2022 Feb 9;13:849140. doi: 10.3389/fimmu.2022.849140. eCollection 2022.
4
CD8 T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.针对 SARS-CoV-2 核衣壳表位具有特异性的 CD8 T 细胞表现出高的初始前体频率和 TCR 多样性。
Immunity. 2021 May 11;54(5):1066-1082.e5. doi: 10.1016/j.immuni.2021.04.009. Epub 2021 Apr 15.
5
Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.急危重症高血压患者的 SARS-CoV-2 特异性动态免疫。
Front Immunol. 2020 Dec 10;11:596684. doi: 10.3389/fimmu.2020.596684. eCollection 2020.
6
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.CD4+ T 细胞损耗共享：当 COVID-19 和 HIV 在免疫系统上交锋时。
Front Immunol. 2020 Dec 15;11:596631. doi: 10.3389/fimmu.2020.596631. eCollection 2020.
7
Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak.细胞因子风暴的不同特点：引发 COVID-19 的 SARS-CoV-2（新型冠状病毒）与引发 SARS 疫情的原始 SARS 病毒的细胞因子特征不同。
J Glob Antimicrob Resist. 2021 Mar;24:90-92. doi: 10.1016/j.jgar.2020.11.005. Epub 2020 Nov 23.
8
PD-1-Expressing SARS-CoV-2-Specific CD8 T Cells Are Not Exhausted, but Functional in Patients with COVID-19.PD-1 表达的 SARS-CoV-2 特异性 CD8 T 细胞并未衰竭，而是在 COVID-19 患者中具有功能。
Immunity. 2021 Jan 12;54(1):44-52.e3. doi: 10.1016/j.immuni.2020.12.002. Epub 2020 Dec 14.
9
Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.2019年冠状病毒病的免疫学特征：T细胞功能耗竭与细胞因子风暴
J Clin Immunol. 2020 Oct;40(7):974-976. doi: 10.1007/s10875-020-00824-4. Epub 2020 Jul 10.
10
Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.COVID-19 患者经体外血液净化治疗后，细胞因子风暴得到成功控制，病情得到恢复。
Int J Infect Dis. 2020 Jul;96:618-620. doi: 10.1016/j.ijid.2020.05.065. Epub 2020 May 26.
引用本文的文献
1
(PD-L1) negatively regulates M1 macrophage polarization in ALI/ARDS.（PD-L1）负向调控 ALI/ARDS 中的 M1 型巨噬细胞极化。
Front Immunol. 2024 Feb 19;15:1344805. doi: 10.3389/fimmu.2024.1344805. eCollection 2024.
2
Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.SARS-CoV-2 通过上调 PD-L1 促进免疫逃逸。
J Med Virol. 2023 Feb;95(2):e28478. doi: 10.1002/jmv.28478.
3
Prolonged -CoV-2 Infection With Common Features in Two Patients Receiving Anti-CD20 Therapy.两名接受抗 CD20 治疗的患者中出现了具有共同特征的持续性 -CoV-2 感染。
In Vivo. 2023 Jan-Feb;37(1):461-467. doi: 10.21873/invivo.13100.
4
Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers.新冠死亡患者胸腔积液的蛋白质组学分析：炎症标志物增强
Diagnostics (Basel). 2022 Nov 14;12(11):2789. doi: 10.3390/diagnostics12112789.
5
The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection.细胞免疫的稳健性决定了 SARS-CoV-2 感染的命运。
Front Immunol. 2022 Jun 27;13:904686. doi: 10.3389/fimmu.2022.904686. eCollection 2022.
6
Cytokine storm promoting T cell exhaustion in severe COVID-19 revealed by single cell sequencing data analysis.单细胞测序数据分析揭示细胞因子风暴促进重症 COVID-19 中的 T 细胞耗竭
Precis Clin Med. 2022 May 23;5(2):pbac014. doi: 10.1093/pcmedi/pbac014. eCollection 2022 Jun.
7
HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19.组蛋白去乙酰化酶抑制作为一种潜在的治疗策略，可恢复重症 COVID-19 中失调的免疫反应。
Front Immunol. 2022 May 3;13:841716. doi: 10.3389/fimmu.2022.841716. eCollection 2022.
8
Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling.通过数学建模识别 COVID-19 严重程度和后遗症的免疫和临床预测因子。
Front Immunol. 2022 Apr 20;13:865845. doi: 10.3389/fimmu.2022.865845. eCollection 2022.
9
Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients.抑制性免疫检查点受体和配体作为 COVID-19 患者的预后生物标志物。
Front Immunol. 2022 Mar 31;13:870283. doi: 10.3389/fimmu.2022.870283. eCollection 2022.
10
Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients.重症 COVID-19 患者甲基强的松龙治疗的严重程度生物标志物动力学及免疫学特征
Front Immunol. 2022 Mar 8;13:758946. doi: 10.3389/fimmu.2022.758946. eCollection 2022.
Zotero 插件